Compare PEB & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEB | NEOG |
|---|---|---|
| Founded | 2009 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2009 | 1989 |
| Metric | PEB | NEOG |
|---|---|---|
| Price | $12.29 | $9.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $12.35 | $10.67 |
| AVG Volume (30 Days) | 2.1M | ★ 4.2M |
| Earning Date | 02-25-2026 | 01-08-2026 |
| Dividend Yield | ★ 0.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,464,126,000.00 | $880,319,000.00 |
| Revenue This Year | $2.11 | N/A |
| Revenue Next Year | N/A | $2.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.99 | N/A |
| 52 Week Low | $7.42 | $3.87 |
| 52 Week High | $14.21 | $12.07 |
| Indicator | PEB | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 63.55 | 71.24 |
| Support Level | $12.01 | $8.44 |
| Resistance Level | $12.95 | $9.78 |
| Average True Range (ATR) | 0.42 | 0.48 |
| MACD | 0.04 | 0.15 |
| Stochastic Oscillator | 64.66 | 68.77 |
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.